Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All HCQ studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19hcq.org COVID-19 treatment researchHCQHCQ (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication

Hong et al., Infect. Chemother., 2020, doi:10.3947/ic.2020.52.3.396
Jul 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Prolonged viral shedding.. 65% Improvement Relative Risk HCQ for COVID-19  Hong et al.  EARLY TREATMENT Is early treatment with HCQ beneficial for COVID-19? Retrospective 90 patients in South Korea Improved viral clearance with HCQ (p=0.001) c19hcq.org Hong et al., Infect. Chemother., 2020, Jul 2020 FavorsHCQ Favorscontrol 0 0.5 1 1.5 2+
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020
 
*, now with p < 0.00000000001 from 411 studies, recognized in 46 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,300+ studies for 75 treatments. c19hcq.org
HCQ 1-4 days from diagnosis was the only protective factor against prolonged viral shedding found, OR 0.111, p=0.001. 57.1% viral clearance with 1-4 days delay vs. 22.9% for 5+ days delayed treatment. Authors report that early administration of HCQ significantly ameliorates inflammatory cytokine secretion and that COVID-19 patients should be administrated HCQ as soon as possible. 42 patients with HCQ 1-4 days from diagnosis, 48 with HCQ 5+ days from diagnosis.
risk of prolonged viral shedding, early vs. late HCQ, 64.9% lower, RR 0.35, p = 0.001, treatment 42, control 48, odds ratio converted to relative risk.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Hong et al., 16 Jul 2020, retrospective, South Korea, peer-reviewed, 7 authors, dosage not specified.
This PaperHCQAll
Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication
Kyung Soo Hong, Jong Geol Jang, Jian Hur, Jong Ho Lee, PhD Hong Nam Kim, PhD Wonhwa Lee, June Hong Ahn
Infection & Chemotherapy, doi:10.3947/ic.2020.52.3.396
There are no proven therapeutics for Coronavirus disease 2019 (COVID-19) pneumonia outbreak. We observed and analyzed the clinical efficacy of the most used hydroxychloroquine (HCQ) for 30 days. In this study, administration of HCQ <5 days from diagnosis (odds ratio: 0.111, 95% confidence interval: 0.034 -0.367, P = 0.001) was the only protective factor for prolonging of viral shedding in COVID-19 patients. Early administration of HCQ significantly ameliorates inflammatory cytokine secretion by eradicating COVID-19, at discharge. Our findings suggest that patients confirmed of COVID-19 infection should be administrated HCQ as soon as possible.
References
Ards Definition, Force, Ranieri, Rubenfeld, Thompson et al., Acute respiratory distress syndrome: the Berlin Definition, JAMA
Boulware, Pullen, Bangdiwala, Pastick, Lofgren et al., A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19, N Engl J Med
Du, Yu, Li, Li, Qin et al., Duration for carrying SARS-CoV-2 in COVID-19 patients, J Infect, doi:10.1016/j.jinf.2020.03.053
Hong, Lee, Kim, Huh, Lee et al., Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea, Ann Lab Med, doi:10.3343/alm.2020.40.5.351
Liu, Yan, Wan, Xiang, Le et al., Viral dynamics in mild and severe cases of COVID-19, Lancet Infect Dis, doi:10.1016/S1473-3099(20)30232-2
Mehta, Mcauley, Brown, Sanchez, Tattersall et al., HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, doi:10.1016/S0140-6736(20)30628-0
Pubmed | Crossref, None, doi:10.1001/jama.2016.0287
Pubmed | Crossref, None, doi:10.1093/cid/ciaa351
Pubmed | Crossref, None, doi:10.1093/cid/ciaa451
Singer, Deutschman, Seymour, Shankar-Hari, Annane et al., The third international consensus definitions for sepsis and septic shock (Sepsis-3), JAMA
Smith, Prytherch, Meredith, Schmidt, Featherstone, The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death, Resuscitation, doi:10.1016/j.resuscitation.2012.12.016
Xu, Chen, Yuan, Yi, Ding et al., Factors associated with prolonged viral RNA shedding in patients with COVID-19, Clin Infect Dis
Zhou, She, Wang, Ma, The duration of viral shedding of discharged patients with severe COVID-19, Clin Infect Dis
Zhou, Yu, Du, Fan, Liu et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, doi:10.1016/S0140-6736(20)30566-3
{ 'indexed': {'date-parts': [[2024, 5, 17]], 'date-time': '2024-05-17T15:40:08Z', 'timestamp': 1715960408273}, 'reference-count': 11, 'publisher': 'Korean Society of Infectious Diseases and Korean Society for Chemotherapy', 'issue': '3', 'license': [ { 'start': { 'date-parts': [[2020, 1, 1]], 'date-time': '2020-01-01T00:00:00Z', 'timestamp': 1577836800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc/4.0/'}], 'funder': [ { 'DOI': '10.13039/501100003725', 'name': 'National Research Foundation of Korea', 'doi-asserted-by': 'publisher', 'award': ['2018R1A2A3075013', 'NRF-2016M3C7A1913845']}], 'content-domain': {'domain': ['icjournal.org'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2020]]}, 'DOI': '10.3947/ic.2020.52.3.396', 'type': 'journal-article', 'created': {'date-parts': [[2020, 9, 28]], 'date-time': '2020-09-28T06:10:31Z', 'timestamp': 1601273431000}, 'page': '396', 'update-policy': 'http://dx.doi.org/10.3947/crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 11, 'title': 'Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus ' '2 Eradication', 'prefix': '10.3947', 'volume': '52', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-2931-6861', 'authenticated-orcid': False, 'given': 'Kyung Soo', 'family': 'Hong', 'sequence': 'first', 'affiliation': [ { 'name': 'Division of Pulmonology and Allergy, Department of Internal ' 'Medicine, College of Medicine, Yeungnam University and Regional ' 'Center for Respiratory Diseases, Yeungnam University Medical ' 'Center, Daegu, Korea.'}]}, { 'ORCID': 'http://orcid.org/0000-0001-8040-5363', 'authenticated-orcid': False, 'given': 'Jong Geol', 'family': 'Jang', 'sequence': 'additional', 'affiliation': [ { 'name': 'Division of Pulmonology and Allergy, Department of Internal ' 'Medicine, College of Medicine, Yeungnam University and Regional ' 'Center for Respiratory Diseases, Yeungnam University Medical ' 'Center, Daegu, Korea.'}]}, { 'ORCID': 'http://orcid.org/0000-0003-3219-8368', 'authenticated-orcid': False, 'given': 'Jian', 'family': 'Hur', 'sequence': 'additional', 'affiliation': [ { 'name': 'Division of Infection, Department of Internal Medicine, College ' 'of Medicine, Yeungnam University, Yeungnam University Medical ' 'Center, Daegu, Korea.'}]}, { 'ORCID': 'http://orcid.org/0000-0002-6837-838X', 'authenticated-orcid': False, 'given': 'Jong Ho', 'family': 'Lee', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Laboratory Medicine, College of Medicine, Yeungnam ' 'University, Yeungnam University Medical Center, Daegu, Korea.'}]}, { 'ORCID': 'http://orcid.org/0000-0002-0329-0029', 'authenticated-orcid': False, 'given': 'Hong Nam', 'family': 'Kim', 'sequence': 'additional', 'affiliation': [ { 'name': 'Center for BioMicrosystems, Brain Science Institute, Korea ' 'Institute of Science and Technology (KIST), Seoul, Korea.'}]}, { 'ORCID': 'http://orcid.org/0000-0003-4336-5221', 'authenticated-orcid': False, 'given': 'Wonhwa', 'family': 'Lee', 'sequence': 'additional', 'affiliation': [ { 'name': 'Aging Research Center, Korea Research Institute of Bioscience ' 'and Biotechnology, Daejeon, Korea.'}]}, { 'ORCID': 'http://orcid.org/0000-0001-7104-8325', 'authenticated-orcid': False, 'given': 'June Hong', 'family': 'Ahn', 'sequence': 'additional', 'affiliation': [ { 'name': 'Division of Pulmonology and Allergy, Department of Internal ' 'Medicine, College of Medicine, Yeungnam University and Regional ' 'Center for Respiratory Diseases, Yeungnam University Medical ' 'Center, Daegu, Korea.'}]}], 'member': '2343', 'reference': [ { 'key': '10.3947/ic.2020.52.3.396_ref1', 'doi-asserted-by': 'crossref', 'first-page': '1054', 'DOI': '10.1016/S0140-6736(20)30566-3', 'volume': '395', 'author': 'Zhou', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.3947/ic.2020.52.3.396_ref2', 'author': 'Xu', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.3947/ic.2020.52.3.396_ref3', 'author': 'Zhou', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.3947/ic.2020.52.3.396_ref4', 'doi-asserted-by': 'crossref', 'first-page': '351', 'DOI': '10.3343/alm.2020.40.5.351', 'volume': '40', 'author': 'Hong', 'year': '2020', 'journal-title': 'Ann Lab Med'}, { 'key': '10.3947/ic.2020.52.3.396_ref5', 'doi-asserted-by': 'crossref', 'first-page': '465', 'DOI': '10.1016/j.resuscitation.2012.12.016', 'volume': '84', 'author': 'Smith', 'year': '2013', 'journal-title': 'Resuscitation'}, { 'key': '10.3947/ic.2020.52.3.396_ref6', 'first-page': '2526', 'volume': '307', 'author': 'ARDS Definition Task Force', 'year': '2012', 'journal-title': 'JAMA'}, { 'key': '10.3947/ic.2020.52.3.396_ref7', 'doi-asserted-by': 'crossref', 'first-page': '801', 'DOI': '10.1001/jama.2016.0287', 'volume': '315', 'author': 'Singer', 'year': '2016', 'journal-title': 'JAMA'}, { 'key': '10.3947/ic.2020.52.3.396_ref8', 'doi-asserted-by': 'crossref', 'first-page': '1033', 'DOI': '10.1016/S0140-6736(20)30628-0', 'volume': '395', 'author': 'Mehta', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.3947/ic.2020.52.3.396_ref9', 'author': 'Boulware', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.3947/ic.2020.52.3.396_ref10', 'doi-asserted-by': 'crossref', 'first-page': 'e78', 'DOI': '10.1016/j.jinf.2020.03.053', 'volume': '81', 'author': 'Du', 'year': '2020', 'journal-title': 'J Infect'}, { 'key': '10.3947/ic.2020.52.3.396_ref11', 'doi-asserted-by': 'crossref', 'first-page': '656', 'DOI': '10.1016/S1473-3099(20)30232-2', 'volume': '20', 'author': 'Liu', 'year': '2020', 'journal-title': 'Lancet Infect Dis'}], 'container-title': 'Infection &amp; Chemotherapy', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://icjournal.org/pdf/10.3947/ic.2020.52.3.396', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://icjournal.org/DOIx.php?id=10.3947/ic.2020.52.3.396', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://icjournal.org/DOIx.php?id=10.3947/ic.2020.52.3.396', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2020, 9, 28]], 'date-time': '2020-09-28T06:16:06Z', 'timestamp': 1601273766000}, 'score': 1, 'resource': {'primary': {'URL': 'https://icjournal.org/DOIx.php?id=10.3947/ic.2020.52.3.396'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020]]}, 'references-count': 11, 'journal-issue': {'issue': '3', 'published-print': {'date-parts': [[2020]]}}, 'URL': 'http://dx.doi.org/10.3947/ic.2020.52.3.396', 'relation': {}, 'ISSN': ['2093-2340', '2092-6448'], 'subject': [], 'container-title-short': 'Infect Chemother', 'published': {'date-parts': [[2020]]}, 'assertion': [ { 'value': '2020-05-23', 'name': 'received', 'label': 'Received', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2020-06-29', 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2020-07-16', 'name': 'published_online', 'label': 'Published online', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': 'Copyright © 2020 by The Korean Society of Infectious Diseases, Korean Society ' 'for Antimicrobial Therapy, and The Korean Society for AIDS', 'name': 'copyright', 'label': 'Copyright', 'group': {'name': 'Copyright_and_licensing', 'label': 'Copyright and Licensing'}}, { 'value': 'This is an Open Access article distributed under the terms of the Creative ' 'Commons Attribution Non-Commercial License ' '(https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted ' 'non-commercial use, distribution, and reproduction in any medium, provided the ' 'original work is properly cited.', 'name': 'license', 'label': 'License', 'explanation': {'URL': 'https://creativecommons.org/licenses/by-nc/4.0/'}, 'group': {'name': 'Copyright_and_licensing', 'label': 'Copyright and Licensing'}}]}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit